OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis
Séverine Loisel‐Meyer, Pauline Lansiaux, Delphine Rossille, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 4, pp. 194-206
Open Access | Times Cited: 15
Séverine Loisel‐Meyer, Pauline Lansiaux, Delphine Rossille, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 4, pp. 194-206
Open Access | Times Cited: 15
Showing 15 citing articles:
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102476-102476
Open Access | Times Cited: 31
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102476-102476
Open Access | Times Cited: 31
Regulatory B Cells—Immunopathological and Prognostic Potential in Humans
Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 357-357
Open Access | Times Cited: 16
Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 357-357
Open Access | Times Cited: 16
Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis
David Abraham, Alain Lescoat, Richard Stratton
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101252-101252
Open Access | Times Cited: 15
David Abraham, Alain Lescoat, Richard Stratton
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101252-101252
Open Access | Times Cited: 15
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis
Maheswari Muruganandam, Angie Ariza‐Hutchinson, Rosemina A Patel, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4633-4660
Open Access | Times Cited: 21
Maheswari Muruganandam, Angie Ariza‐Hutchinson, Rosemina A Patel, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4633-4660
Open Access | Times Cited: 21
International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges
Abdulrahman Alsultan, Dominique Farge, Sven Kili, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1132-1140
Open Access | Times Cited: 6
Abdulrahman Alsultan, Dominique Farge, Sven Kili, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1132-1140
Open Access | Times Cited: 6
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis
Filomena Napolitano, Valentina Giudice, Vittoria D’Esposito, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Filomena Napolitano, Valentina Giudice, Vittoria D’Esposito, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation
Abbas Ali Qayyum, Thomas Kromann Lund, Pia Bredahl Jensen, et al.
JHLT Open (2025), pp. 100254-100254
Open Access
Abbas Ali Qayyum, Thomas Kromann Lund, Pia Bredahl Jensen, et al.
JHLT Open (2025), pp. 100254-100254
Open Access
Biomarkers in Systemic Sclerosis: An Overview
Giuseppe Maggio, Paola Confalonieri, Francesco Salton, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7775-7802
Open Access | Times Cited: 9
Giuseppe Maggio, Paola Confalonieri, Francesco Salton, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7775-7802
Open Access | Times Cited: 9
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Yang Han, Sousan Cheong, Yunfan He, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Yang Han, Sousan Cheong, Yunfan He, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches
Alain Lescoat, Hiroshi Kato, John Varga
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 6, pp. 356-363
Closed Access | Times Cited: 8
Alain Lescoat, Hiroshi Kato, John Varga
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 6, pp. 356-363
Closed Access | Times Cited: 8
Regulatory B cells in autoimmune diseases: Insights and therapeutic potential
Q. Y. Su, Zhongqing Jiang, Xinqiang Song, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103326-103326
Closed Access | Times Cited: 2
Q. Y. Su, Zhongqing Jiang, Xinqiang Song, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103326-103326
Closed Access | Times Cited: 2
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study
Dominique Farge, Lucie Biard, Ben Weil, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 2
Dominique Farge, Lucie Biard, Ben Weil, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 2
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
CART Cells and Other Cell Therapies (ie MSC, Tregs) in Autoimmune Diseases
Raffaella Greco, Dominique Farge
Springer eBooks (2024), pp. 837-848
Closed Access
Raffaella Greco, Dominique Farge
Springer eBooks (2024), pp. 837-848
Closed Access
Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium
Marianela Brizio, Mathieu Mancini, Maximilien Lora, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
Marianela Brizio, Mathieu Mancini, Maximilien Lora, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
